摘要
目的:探讨奥兰扎平、利培酮及氯丙嗪对男性精神分裂症患者催乳素(PRL)水平及勃起功能的影响。方法:60例首发男性精神分裂症患者随机分为奥兰扎平组、利培酮组及氯丙嗪组,检测治疗前、入组4周末及8周末PRL水平,利用男性勃起功能量表评估入组12周末勃起功能状况。结果:入组4周末利培酮组血清PRL水平显著高于氯丙嗪组及奥兰扎平组,氯丙嗪组勃起功能量表分显著低于奥兰扎平组。结论:奥兰扎平对催乳素水平及男性勃起功能的影响相对较小。
Objective:To investigate the effects of olanzapine, risperidone and chlorpromazine on prolactin and erectile function in male patients with schizophrenia. Methods: 60 first onset male inpatients with schizophrenia according to CCMD-3 criteria were randomly divided into three groups receiving the treatment of olanzapine, risperidone and chlorpromazine respectively.Before treatment and 4 weeks and 8 weeks after treatment, the serum prolactin level was detected. After 12 weeks of treatment, the erectile function was evaluated. Resuits:As the serum level of PRL in risperidone group at the end of 4 weeks was significantly higher than that in olanzapine group and chlorpromazine group.The patients treated with chlorpromazine had significantly lower erectile function score than the patients treated with olanzapine.Conelusion:Olartzapine has less influence on level of prolactin than risperidone and has less influence on male erectile function than chlorpromazine.
出处
《现代医药卫生》
2008年第14期2077-2078,共2页
Journal of Modern Medicine & Health
关键词
奥兰扎平
利培酮
氯丙嗪
精神分裂症
催乳素
勃起功能
Olanzapine
Rispcridone
Chlorpromazine
Schizophrenia
Prolacfin
Erectile function